|
Delayed
Australian S.E.
22:29:54 2026-10-06 EDT
|
5-day change | 1st Jan Change | ||
| 0.2900 AUD | +7.41% |
|
+11.54% | -71.57% |
| 09-16 | Epiminder Says US Clinical Study Evaluating Epilepsy Monitoring Platform Enrolls 75th Patient | MT |
| 08-25 | Epiminder Limited Reports Earnings Results for the Full Year Ended June 30, 2026 | CI |
Company Valuation: Epiminder Limited
Data adjusted to current consolidation scope
| Fiscal Period: June | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|
| Market Cap 1 | 69.33 | 58.5 | - | - |
| Change | - | -15.62% | - | - |
| Enterprise Value (EV) 1 | -6.459 | -2.01 | -50.69 | -26.77 |
| Change | - | 68.88% | -2,421.28% | 47.19% |
| P/E | -1.13x | -1.32x | -2.48x | -4.82x |
| PBR | 0.85x | 1.54x | 0.64x | 0.74x |
| PEG | - | 0x | 0.1x | 0.1x |
| Capitalization / Revenue | - | - | 9.7x | 2.97x |
| EV / Revenue | - | - | -8.4x | -1.36x |
| EV / EBITDA | 0.16x | 0.04x | 1.6x | 1.04x |
| EV / EBIT | 0.16x | 0.04x | 1.6x | 1.04x |
| EV / FCF | 0.15x | 0.04x | 1.55x | 0.91x |
| FCF Yield | 671% | 2,368% | 64.5% | 110% |
| Dividend per Share 2 | - | - | - | - |
| Rate of return | - | - | - | - |
| EPS 2 | -0.2833 | -0.204 | -0.109 | -0.056 |
| Distribution rate | - | - | - | - |
| Net sales 1 | - | - | 6.031 | 19.67 |
| EBITDA 1 | -41.47 | -51.05 | -31.69 | -25.69 |
| EBIT 1 | -41.51 | -51.06 | -31.75 | -25.7 |
| Net income 1 | -42.73 | -49.25 | -30.6 | -18.75 |
| Net Debt 1 | -75.79 | -60.51 | -109.2 | -85.27 |
| Reference price 2 | 0.3200 | 0.2700 | 0.2700 | 0.2700 |
| Nbr of stocks (in thousands) | 216,672 | 216,672 | - | - |
| Announcement Date | 8/25/26 | - | - | - |
1AUD in Million2AUD
Estimates
P/E, Detailed evolution
| P/E (Y) | EV / Sales (Y) | EV / EBITDA (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.3x | - | 0.06x | - | 40.02M | |
| 33.63x | 5.87x | 22.5x | 0.27% | 250B | |
| 37.48x | 6.69x | 21.17x | 0.67% | 156B | |
| 44.05x | 11.66x | 25.72x | -.--% | 144B | |
| 16.03x | 3.31x | 10.8x | -.--% | 61.45B | |
| 34.47x | 6.9x | 21.87x | -.--% | 50.28B | |
| 33.36x | 6.6x | 22.41x | 0.6% | 48.29B | |
| 18.42x | 2.25x | 11.43x | 2.73% | 46.73B | |
| 43.4x | 10.52x | 23.2x | -.--% | 45.89B | |
| 59.38x | 9.57x | 33.77x | -.--% | 44.35B | |
| Average | 31.89x | 7.04x | 19.29x | 0.48% | 84.64B | |
| Weighted average by Cap. | 35.90x | 7.17x | 21.93x | 0.39% |
Y-o-Y evolution of P/E
Historical PBR trend
Evolution Enterprise Value / Sales
Change in Enterprise Value/EBITDA
- Stock Market
- Stocks
- EPI Stock
- Valuation Epiminder Limited
Select your edition
All financial news and data tailored to specific country editions
